Status:
COMPLETED
Characteristics of Postinfectious Cough
Lead Sponsor:
Kefang Lai
Conditions:
Cough
Eligibility:
All Genders
18-70 years
Brief Summary
Collect the age, sex and other demographic data of 1600 patients with chronic cough after COVID-19 infection and clinical parameters such as cough characteristics, establish a cohort of patients with ...
Detailed Description
1. Formulate clinical data registration questionnaire (including baseline and follow-up) Adopt the form of online questionnaire survey, unify the inclusion criteria, and register the demographic chara...
Eligibility Criteria
Inclusion
- Age between 18-70 years old, gender not limited;
- After COVID-19 infection (COVID-19 nucleic acid test or antigen test is positive, or there is a highly suspected symptom of COVID-19 infection), the cough lasts for more than 3 weeks and there is still cough at the time of investigation;
- No obvious abnormalities were found in chest imaging.
Exclusion
- Combined with other respiratory infectious diseases (pneumonia, tuberculosis, etc.);
- Combined chronic respiratory diseases (asthma, chronic obstructive pulmonary disease, bronchiectasis, interstitial lung disease, etc.);
- Cough and expectoration were found 2 months before COVID-19 infection;
- Merge other serious organ diseases and malignant tumors;
- Pregnant and lactating women.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
1650 Patients enrolled
Trial Details
Trial ID
NCT06951321
Start Date
March 1 2023
End Date
April 1 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120